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Abstract The predominant molecular symptom of
ageing is the accumulation of altered gene products.
Nutritional studies show that ageing in animals can be
signiﬁcantly inﬂuenced by dietary restriction. Genet-
ics has revealed that ageing may be controlled by
changes in intracellular NAD/NADH ratio regulating
sirtuin activity. Physiological and other approaches
indicate that mitochondria may also regulate ageing.
A mechanism is proposed which links diet, exercise
and mitochondria-dependent changes in NAD/NADH
ratio to intracellular generation of altered proteins. It
is suggested that ad libitum feeding conditions
decrease NAD availability which also decreases
metabolism of the triose phosphate glycolytic
intermediates, glyceraldehyde-3-phosphate and dihy-
droxyacetone-phosphate, which can spontaneously
decompose into methylglyoxal (MG). MG is a highly
toxic glycating agent and a major source of protein
advanced-glycosylation end-products (AGEs). MG
and AGEs can induce mitochondrial dysfunction and
formation of reactive oxygen species (ROS), as well
as affect gene expression and intracellular signalling.
In dietary restriction–induced fasting, NADH would
be oxidised and NAD regenerated via mitochondrial
action. This would not only activate sirtuins and
extend lifespan but also suppress MG formation. This
proposal can also explain the apparent paradox
whereby increased aerobic activity suppresses forma-
tion of glycoxidized proteins and extends lifespan.
Variation in mitochondrial DNA composition and
consequent mutation rate, arising from dietary-con-
trolled differences in DNA precursor ratios, could also
contribute to tissue differences in age-related mito-
chondrial dysfunction.
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NAD and life-span
Genetic studies using a range of organisms have
indicated that enzymes called sirtuins are linked to
the control of ageing and life-span (Longo and
Kennedy 2006; Leibiger and Berggren 2006; Lin
and Guarente 2003). Sirtuins catalyse NAD-depen-
dent deacetylation of histones (and other proteins)
with the concomitant release of nicotimanide and
O-acetyl-ADP-ribose (Howitz et al. 2003). Other
studies have suggested that metabolism of the redox
couple NAD/NADH provides a link between sirtuin
activity and the control of cell senescence and
organism life-span (Denu 2003, 2007; Belenky et al.
2007; Bordone and Guarente 2005): NAD-dependent
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phenotype, whereas inhibition of deacetylation
activity by NADH or nicotinamide, or by NAD
unavailability, promote the onset of cellular aging
and decrease organism lifespan.
Ageing, dietary restriction and NAD
Ageing can be delayed in various organisms by
dietary restriction (DR) induced by a permanent
decrease in calorie intake (called caloric restriction—
CR). Recent observations have shown that an inter-
mittent feeding (IF) protocol, which need not involve
any overall reduction in calorie intake, can also delay
ageing (Martin et al. 2006; Masternak et al. 2005;
Mattson and Wan 2005). The mechanisms by which
DR delays ageing and increases life-span are far from
completely understood (Sinclair 2005). It is likely,
however, that both CR and IF promote similar effects
on the frequency of glycolysis and subsequent fasting
periods (Hipkiss 2006a and 2007), i.e. glycolysis
would be discontinuous, only operating post-prandi-
aly. In contrast, glycolysis would be almost
continuous under ad libitum (AL) feeding conditions.
It is suggested that during the periods of fasting
(induced by either CR or IF) the NAD/NADH ratio
would differ from that prevailing in the AL case
where fasting would be unlikely or negligible. In the
AL condition, continuous glycolytic throughput
would tend to provoke an accumulation of NADH
and lower NAD availability, whereas the CR- and IF-
induced fasting would decrease glycolytic NAD
demand and increase NADH oxidation and NAD
regeneration.
Ageing and accumulation of altered proteins
At the biochemical level ageing is characterized by
the accumulation of altered protein molecules. The
changes in protein structure result from intrinsic
polypeptide instability as well as the actions of
deleterious endogenous and exogenous agents (see
Hipkiss 2006b; Schoneich 2006 and refs. therein). As
yet it is unclear how changes in NAD metabolism
might induce generation of altered proteins which
characterise the aged phenotype.
Protein glycation and ageing
Formation of protein advanced glycation end-prod-
ucts (AGEs) is an important consequence of ageing
and is increased particularly under conditions of
uncontrolled glucose metabolism (e.g. hyperglyca-
emia) (see Ahmed and Thornally 2007; Thornalley
2007 and refs. therein for recent reviews). Protein
AGEs can themselves induce inﬂammatory conditions
and provoke production of reactive oxygen species
(ROS) which can further compromise cell function.
Indeed recent studies have shown that decreasing
dietary AGE intake preserves defence functions
against oxidative stress and decreases tissue damage
in humans, and extends lifespan in mice, while
increasing dietary AGE intake is correspondingly
deleterious and accelerates ageing and decreases life-
span (Cai et al. 2007; Uribarri et al. 2007a, b). Hence
it is at least conceivable that decreasing metaboli-
cally-generated protein AGEs could help decrease the
overall AGE load and could have beneﬁcial effects by
suppressing ageing and extending lifespan.
NAD and accumulation of methylglyoxal,
an endogenous glycating agent
NAD is essential for the metabolism of the glycolytic
intermediate glyceraldehyde-3-phosphate (G3P) via
the action of glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH), generating 1,3-diphosphoglycerate
(1,3DPG) and NADH as products. It is argued above
that in the AL condition, glycolysis would be
continuous, which would tend to lower NAD levels
and raise NADH levels. This would occur especially
should mitochondrial-mediated NADH re-oxidation
to NAD be correspondingly lowered to compensate
for the extra ATP synthesised via glycolysis, assum-
ing cellular ATP demand remains unchanged.
Limitation of NAD availability would lower GAPDH
activity and promote an accumulation of G3P. The
immediate precursor of G3P is dihydroxyacetone
phosphate (DHAP); both of these trioses can glycate
proteins. More importantly, however, is the fact that
both G3P and DHAP can spontaneously decompose
into methylglyoxal (MG), a highly toxic and very
reactive glycating agent. It is likely therefore that
changes in NAD availability could strongly inﬂuence
MG production.
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glycolytic frequency could help explain why dietary
restriction delays cellular and organism aging, possi-
bly due to decreased MG generation during DR
conditions (Hipkiss 2006a). MG is a highly active
glycating agent which is thought to be responsible for
the increased protein/lipid glycation detected during
hyperglycaemic conditions and for much of the
protein/lipid glycation associated with diabetic com-
plications (Ahmed and Thornalley 2007; Thornalley
2007). Although MG is a normal cellular constituent,
its excessive production is deleterious (plasma MG
levels are raised to around 800 nmol/l in young
diabetics compared to about 400 nmol/l in young non-
diabetic subjects, (Han et al. 2007)). Importantly, MG
can induce many of the deleterious physiological and
biochemical changes characteristic of the aged phe-
notype, including increased ROS generation,
mitochondrial dysfunction, apoptosis and inhibition
of cell division (see Hipkiss 2006a and refs therein).
A number of studies, some very recent, reinforce
the notion that changes in cellular MG content are
important determinants of the formation of altered
protein that characterise senescence (Gomes et al.
2006). Even at non-toxic concentrations, MG can
inﬂuence cell proliferation by forming adducts with
growth factor receptors (Cantero et al. 2007). MG
can also inhibit the activity of GAPDH (Lee et al.
2005), causing triose phosphate accumulation and
thereby increasing MG generation, and so inducing a
highly deleterious cycle. MG can induce apoptosis
(Nicolay et al. 2006) and also affect gene expression
and signal transduction, at least in cultured cells (Du
et al. 2003; Yao et al. 2006; Ramasamy et al. 2006).
Two studies in Drosophila have shown that mutation
in triosephosphate isomerase (the enzyme which
converts DHAP into G3P, preceding GAPDH in the
glycolytic pathway, and which is known to undergo
age-related post-synthetic modiﬁcation in vivo
(Gracy et al. 1990)) is highly deleterious, causing
paralysis, neurodegeneration and decreases life-span
(Gnerer et al. 2006; Celotto et al. 2006), possibly
because of MG accumulation. Human studies have
shown that a deﬁciency in triosephosphate isomerase
activity, causes increases in the levels of both DHAP
(up to 20-fold (Schneider 2000)) and MG (Ahmed
et al. 2003), and induces neuromuscular degeneration
and early death (Schneider et al. 1965; Valentine
1966). Other studies have shown that MG induces
apoptosis in neutrophils (Gawlowski et al. 2007),
inhibits extracellular matrix remodelling (Chong
et al. 2007) and can interfere with the stress response
(Oya-Ito et al. 2006) by suppressing NF-kappaB-
responsive gene activation (Laga et al. 2007).
Hence it is reasonable to suggest that any increased
MGgeneratedinALfedanimals,comparedtoanimals
subjected to CR or IF, could make a signiﬁcant
contributiontocellulardysfunction.Duringthefasting
periods in DR animals, NADH generated during
glycolysis would be oxidized mitochondrially for
ATP production, and NAD would be regenerated
thereby allowing continued G3P metabolism, and
preventing triose phosphate accumulation and conse-
quently suppressing MG generation. This condition
would decrease MG-induced macromolecular glycox-
idation, mitochondrial damage, dysfunctional
signalling and gene expression, as described above.
Such a scenario is consistent with the ﬁndings that
raising NAD levels, or lowering NADH levels by
increasing its oxidation, also promote sirtuin activa-
tion, with concomitant beneﬁcial effects on cell
survival etc. Table 1 illustrates the interrelationship
and overlap between sirtuin regulation, generation of
altered proteins and mitochondrial activity, exerted by
metabolic effects on NAD and NADH levels.
Anysituationsuchasfastingwhich maintainsNAD
levels, either via regeneration from NADH, or by
synthesis de novo or via a scavenging pathway, would
facilitate metabolism of the MG precursors G3P and
DHAP, and so decrease the incidence of MG-induced
macromolecular damage. The increase in free-radical-
mediated damage which occurs during AL feeding,
comparedtotheCRandIFconditions,mightoccurasa
result of not only MG-induced generation of ROS
following its reaction with proteins etc., but also via
plasma membrane-mediated NAD(P)H-oxidase activ-
ity. Furthermore, because less ATP is required from
mitochondrial function due to continuous ATP syn-
thesis via glycolysis in the AL-fed state, the decreased
supply of electrons (as acetyl-CoA or from NADH) to
the electron transport chain would tend to produce
more incompletely reduced oxygen moieties i.e. oxy-
gen free-radicals. Any increased intra-mitochondrial
ROS production could also increase the probability of
mitochondrial dysfunction.
Protection against MG is afforded by the glyox-
alase system which consists of two enzymes;
glyoxalase I (GLX I), which uses glutathione to
Biogerontology (2008) 9:49–55 51
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lase II (GLX II), which completes the detoxiﬁcation
by generating D-lactate and reduced glutathione.
Over-expression of GLX I can inhibit formation of
hyperglycaemia-induced AGEs (Shinohara et al.
1998), while a deﬁciency in GLX I in humans is
associated with increased protein glycation (Miyata
et al. 2001). GLX II activity may be rate-limiting in
MG detoxiﬁcation; GLX II over-expression is pro-
tective against MG-induced cell death, whilst its
deﬁciency promotes MG-induced cell death (Xu and
Chen 2006). It is also interesting that tumour necrosis
factor can induce phosphorylation of GLX I which
also results in substantial increase in cellular MG
(van Herreweghe et al. 2002).
Tissue differences in ageing susceptibility
Tissues appear to age at different rates as shown by
the varied incidence of dysfunctional mitochondria
between tissues in the same organism. Variation in
tissue susceptibility to MG may reside partly in
differing levels of the glyoxalase system together
with those molecules (glutathione, polyamines, car-
nosine, creatine, pyridoxamine) which normally exert
protective carbonyl scavenging activity towards gly-
cating agents such as MG (Hipkiss 2005; de Arriba
et al. 2006).
Dietary-induced effects on metabolism could con-
ceivably also affect mitochondrial DNA composition
and hence mitochondrial protein structure and func-
tion. It has been found that mitochondrial DNA
mutation rate may vary up to three-fold according to
the relative concentrations of the four deoxyribonu-
cleoside triphosphates in the nucleotide pool (Song
et al.2005;MathewsandSong2007).Itispossiblethat
dietary changes could affect the composition of the
nucleotidepoolandtherebyaffectmitochondrialDNA
composition during its synthesis. Pool composition
could vary between tissues, and any consequent
differencesinmitochondrialDNAmutationratewould
contribute to tissue-speciﬁc age-related mitochondrial
change. Thus mitochondrial dysfunction could be
either a cause or a consequence of ageing (Hipkiss
2003), depending on the prevailing circumstances.
The beneﬁcial effects of functional mitochondria
on NAD regeneration
The recent observations (i) by Belenky et al. (2007)
showing that life-span extension in yeast is dependent
upon NAD synthesis, (ii) that efﬁcient mitochondrial
function was necessary for maximal longevity in yeast
(Piper et al. 2006), and (iii) that mitochondrial
uncoupling, which increases NADH oxidation,
decreases telomere damage and delays senescence in
cultured human ﬁbroblasts (Passos et al. 2007), are
observations entirely consistent with the above pro-
posal. The proposed beneﬁcial effects of NADH
oxidation to regenerate NAD via mitochondrial func-
tion would also help explain how aerobic exercise
may delay development of the aged phenotype
including production of altered proteins, as well as
resolve the apparent paradox that increased oxygen
utilization suppresses age-related change. The efﬁ-
cient regeneration of NAD via effective mitochondrial
function is also consistent with mitochondrial ageing
theories which postulate that mitochondrial dysfunc-
tion is key to the onset of ageing.
Also consistent with the present proposal are the
very recent ﬁndings of Smith et al. (2007) who
concluded that, in the yeast Saccharomyces cerevisiae
at least, elevated respiration is an important determi-
nant of chronological longevity. They observed that
growth on non-fermentable carbon sources, which
forced the cells to employ respiration exclusively,
extended lifespan, but which caloric restriction did not
further enhance. This again illustrates, simplistically
Table 1 Predicted effects of aerobic exercise and fasting induced by caloric restriction or intermittent feeding, on NAD and NADH
levels, methylglyoxal (MG) levels, mitochondrial (mito) activity and sirtuin activity
Conditions NAD NADH MG Mito activity Sirtuin activity
Ad libitum fed Low High High Lowered Lowered
Fasting High Low Low Increased Increased
Aerobic exercise High Low Low Increased Increased
Increased MG levels are partly responsible for the increased generation of altered proteins that accompanies ageing
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respiration and the deleterious effects of glycolysis,
both possibly mediated via changes NAD and NADH
levels, which in turn regulate MG generation. Con-
troversially, however, these authors also found that
caloric restriction-mediated lifespan extension
occurred independently of sirtuin activity in Saccha-
romyces cerevisiae.
Other functions induced by DR
Ageing is a complex phenomenon. It is likely that the
rate-limiting event which increases cellular and hence
organism vulnerability to death may vary according to
circumstances. For example anti-oxidant functions
may not be limiting in conditions where oxidative
stress is not involved. There are an increasing number
of ﬁndings suggesting that proteolytic dysfunction
involving either proteasomes or autophagy cause
altered protein to accumulate and compromise cell
survival and which can be affected by dietary
restriction (Bergamini et al. 2003). Conversely acti-
vation of autophagy by inhibiting the target of
rapamycin (TOR) signalling pathway can increase
lifespan, at least in yeast (Bonawitz et al. 2007) and a
nematode worm (Henderson et al. 2006). The recent
observation that the sirtuin-like activity, histone
deacetylase 6 (HDAC6), may provide a mechanistic
link between the autophagic and ubiquitin-proteasome
proteolytic systems in Drosophila (Pandey et al.
2007), and the observation that up-regulation of
neuronal sirtuin1 activity elevates the activity of the
a-protease and prevents accumulation of the amyloid
peptide (Qin et al. 2006), support the idea that both
formation and degradation of aberrant proteins are
important for control of ageing and related disorders.
Conclusion
It is proposed that dietary-induced changes in NAD
and NADH levels, as revealed by their regulation of
sirtuin activity, may also control the concentration of
deleterious glycolytic intermediates G3P and DHAP,
and thereby also control formation of MG and
generation of protein AGEs. The accumulation of
MG and protein AGEs may compromise tissue
function including mitochondrial activity and thereby
contribute to organism ageing. Conversely, conditions
that stimulate mitochondrial function will help regen-
erate NAD, maintain sirtuin activity and decrease
formation of protein AGEs, intra- and extra-mito-
chondrial ROS can thereby delay ageing onset.
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